Category: Laser/Light-based Devices
Nearly half of the patients who underwent LASIK laser eye surgery reported problems after the procedure, according to an FDA study, although only 1% said the problems interfered with their daily lives.
Some 45% of patients who had a laser eye surgery called LASIK later reported at least 1 visual symptom 3 months after the procedure, the FDA said yesterday.
Cynosure rounds out its minimally and non-invasive aesthetics portfolio with the $13.2 million acquisition of Ellman Intl. and its radiofrequency devices.
Massachusetts-based Cynosure (NSDQ:CYNO) is looking to expand its market with new radiofrequency-based devices picked up in its $13.2 million acquisition of Ellman Intl.
Ousted CEO Federico Pignatelli turns the spotlight on new leadership at his former company after resigning from the board of directors.
Former Biolase (NSDQ:BIOL) CEO Federico Pignatelli isn't ready to put down his dukes after dropping his seat on the company's board of directors.
St. Jude Medical and Volcano agree to settle all litigation between them, putting to bed years of lawsuits over medical lasers and fractional flow reserve devices.
Biolase's scorned former CEO Federico Pignatelli retires from the board of directors, saying that he was effectively forced out by hostilities from other members.
Former Biolase (NSDQ:BIOL) CEO Federico Pignatelli, who was removed from the corner office by a court order earlier this year, also walked away from the company's board of directors.
LensAR secures another $8 million in an equity funding round in support of its laser-based cataract surgery systems.
Opthalmology devices maker LensAR secured $8 million in equity funding, according to an SEC filing dated July 31, 2014.
The Mass. Supreme Judicial Court denies St. Jude Medical's bid to overturn the portions of a lower court's ruling that went against it in its laser technology spat with Volcano Corp.
The highest court in Massachusetts largely denied